nodes	percent_of_prediction	percent_of_DWPC	metapath
Tafluprost—PTGS2—obesity	0.59	1	CbGaD
Tafluprost—PTGFR—ovarian follicle—obesity	0.0614	0.493	CbGeAlD
Tafluprost—PTGS2—ovarian follicle—obesity	0.0169	0.135	CbGeAlD
Tafluprost—PTGFR—respiratory system—obesity	0.0081	0.065	CbGeAlD
Tafluprost—PTGFR—adipose tissue—obesity	0.00547	0.0439	CbGeAlD
Tafluprost—Iritis—Sibutramine—obesity	0.00501	0.0699	CcSEcCtD
Tafluprost—PTGFR—adrenal gland—obesity	0.00491	0.0394	CbGeAlD
Tafluprost—PTGFR—endocrine gland—obesity	0.00426	0.0342	CbGeAlD
Tafluprost—Bimatoprost—AKR1C3—obesity	0.00398	0.608	CrCbGaD
Tafluprost—PTGFR—liver—obesity	0.00384	0.0308	CbGeAlD
Tafluprost—PTGS2—gall bladder—obesity	0.0036	0.0289	CbGeAlD
Tafluprost—Iritis—Topiramate—obesity	0.00279	0.0388	CcSEcCtD
Tafluprost—Latanoprost—SLC22A1—obesity	0.00257	0.392	CrCbGaD
Tafluprost—PTGS2—islet of Langerhans—obesity	0.00236	0.0189	CbGeAlD
Tafluprost—Ocular hyperaemia—Topiramate—obesity	0.00226	0.0315	CcSEcCtD
Tafluprost—PTGS2—respiratory system—obesity	0.00223	0.0179	CbGeAlD
Tafluprost—Endophthalmitis—Topiramate—obesity	0.00222	0.031	CcSEcCtD
Tafluprost—Vision blurred—Phendimetrazine—obesity	0.00217	0.0303	CcSEcCtD
Tafluprost—Eyelid oedema—Topiramate—obesity	0.0021	0.0292	CcSEcCtD
Tafluprost—Cataract—Sibutramine—obesity	0.002	0.0279	CcSEcCtD
Tafluprost—PTGS2—adrenal cortex—obesity	0.00187	0.015	CbGeAlD
Tafluprost—Vision blurred—Phenylpropanolamine—obesity	0.00186	0.0259	CcSEcCtD
Tafluprost—Lacrimation increased—Bupropion—obesity	0.0018	0.0251	CcSEcCtD
Tafluprost—Visual acuity reduced—Topiramate—obesity	0.00178	0.0248	CcSEcCtD
Tafluprost—Dry eye—Sibutramine—obesity	0.00176	0.0245	CcSEcCtD
Tafluprost—PTGS2—cardiovascular system—obesity	0.00171	0.0137	CbGeAlD
Tafluprost—Photophobia—Bupropion—obesity	0.00156	0.0217	CcSEcCtD
Tafluprost—Vision blurred—Diethylpropion—obesity	0.00154	0.0215	CcSEcCtD
Tafluprost—Dry eye—Bupropion—obesity	0.00154	0.0214	CcSEcCtD
Tafluprost—Eye pain—Sibutramine—obesity	0.00153	0.0214	CcSEcCtD
Tafluprost—PTGS2—pituitary gland—obesity	0.00151	0.0121	CbGeAlD
Tafluprost—PTGS2—adipose tissue—obesity	0.0015	0.0121	CbGeAlD
Tafluprost—Dyspnoea—Phenylpropanolamine—obesity	0.00143	0.02	CcSEcCtD
Tafluprost—PTGS2—digestive system—obesity	0.00142	0.0114	CbGeAlD
Tafluprost—PTGS2—adrenal gland—obesity	0.00135	0.0108	CbGeAlD
Tafluprost—Headache—Methamphetamine—obesity	0.00134	0.0187	CcSEcCtD
Tafluprost—Eye pain—Bupropion—obesity	0.00134	0.0186	CcSEcCtD
Tafluprost—Headache—Benzphetamine—obesity	0.00129	0.018	CcSEcCtD
Tafluprost—Asthma—Orlistat—obesity	0.00124	0.0172	CcSEcCtD
Tafluprost—Asthma—Sibutramine—obesity	0.0012	0.0167	CcSEcCtD
Tafluprost—Dyspnoea—Diethylpropion—obesity	0.00119	0.0166	CcSEcCtD
Tafluprost—Headache—Phendimetrazine—obesity	0.00118	0.0164	CcSEcCtD
Tafluprost—PTGS2—endocrine gland—obesity	0.00117	0.00939	CbGeAlD
Tafluprost—Lacrimation increased—Topiramate—obesity	0.00115	0.016	CcSEcCtD
Tafluprost—Nasopharyngitis—Bupropion—obesity	0.00108	0.015	CcSEcCtD
Tafluprost—Urinary tract infection—Orlistat—obesity	0.00107	0.0149	CcSEcCtD
Tafluprost—PTGS2—liver—obesity	0.00105	0.00847	CbGeAlD
Tafluprost—Asthma—Bupropion—obesity	0.00104	0.0145	CcSEcCtD
Tafluprost—Urinary tract infection—Sibutramine—obesity	0.00104	0.0144	CcSEcCtD
Tafluprost—Photophobia—Topiramate—obesity	0.000994	0.0139	CcSEcCtD
Tafluprost—Dry eye—Topiramate—obesity	0.000978	0.0136	CcSEcCtD
Tafluprost—Headache—Phentermine—obesity	0.000963	0.0134	CcSEcCtD
Tafluprost—Rhinitis—Sibutramine—obesity	0.00096	0.0134	CcSEcCtD
Tafluprost—Urinary tract infection—Bupropion—obesity	0.000904	0.0126	CcSEcCtD
Tafluprost—Eye disorder—Sibutramine—obesity	0.000895	0.0125	CcSEcCtD
Tafluprost—Eye pain—Topiramate—obesity	0.000851	0.0119	CcSEcCtD
Tafluprost—Headache—Diethylpropion—obesity	0.000838	0.0117	CcSEcCtD
Tafluprost—Rhinitis—Bupropion—obesity	0.000837	0.0117	CcSEcCtD
Tafluprost—Vision blurred—Orlistat—obesity	0.000812	0.0113	CcSEcCtD
Tafluprost—Headache—Cimetidine—obesity	0.000797	0.0111	CcSEcCtD
Tafluprost—Vision blurred—Sibutramine—obesity	0.000785	0.0109	CcSEcCtD
Tafluprost—Eye disorder—Bupropion—obesity	0.00078	0.0109	CcSEcCtD
Tafluprost—Cough—Orlistat—obesity	0.000751	0.0105	CcSEcCtD
Tafluprost—Cough—Sibutramine—obesity	0.000727	0.0101	CcSEcCtD
Tafluprost—Nervous system disorder—Orlistat—obesity	0.000689	0.00961	CcSEcCtD
Tafluprost—Nasopharyngitis—Topiramate—obesity	0.000687	0.00958	CcSEcCtD
Tafluprost—Vision blurred—Bupropion—obesity	0.000685	0.00954	CcSEcCtD
Tafluprost—Asthma—Topiramate—obesity	0.000664	0.00926	CcSEcCtD
Tafluprost—Cough—Bupropion—obesity	0.000634	0.00884	CcSEcCtD
Tafluprost—Dyspnoea—Sibutramine—obesity	0.000606	0.00845	CcSEcCtD
Tafluprost—Nervous system disorder—Bupropion—obesity	0.000581	0.0081	CcSEcCtD
Tafluprost—Urinary tract infection—Topiramate—obesity	0.000576	0.00802	CcSEcCtD
Tafluprost—Rhinitis—Topiramate—obesity	0.000533	0.00743	CcSEcCtD
Tafluprost—Dyspnoea—Bupropion—obesity	0.000529	0.00737	CcSEcCtD
Tafluprost—Pruritus—Orlistat—obesity	0.000497	0.00693	CcSEcCtD
Tafluprost—Eye disorder—Topiramate—obesity	0.000497	0.00693	CcSEcCtD
Tafluprost—Pruritus—Sibutramine—obesity	0.000481	0.00671	CcSEcCtD
Tafluprost—Headache—Orlistat—obesity	0.00044	0.00614	CcSEcCtD
Tafluprost—Vision blurred—Topiramate—obesity	0.000436	0.00608	CcSEcCtD
Tafluprost—Headache—Sibutramine—obesity	0.000426	0.00594	CcSEcCtD
Tafluprost—Pruritus—Bupropion—obesity	0.00042	0.00585	CcSEcCtD
Tafluprost—Cough—Topiramate—obesity	0.000404	0.00563	CcSEcCtD
Tafluprost—Headache—Bupropion—obesity	0.000371	0.00518	CcSEcCtD
Tafluprost—Nervous system disorder—Topiramate—obesity	0.00037	0.00516	CcSEcCtD
Tafluprost—Dyspnoea—Topiramate—obesity	0.000337	0.00469	CcSEcCtD
Tafluprost—Pruritus—Topiramate—obesity	0.000267	0.00372	CcSEcCtD
Tafluprost—Headache—Topiramate—obesity	0.000237	0.0033	CcSEcCtD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—obesity	7.48e-05	0.000361	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HK2—obesity	7.48e-05	0.000361	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ALOX12—obesity	7.37e-05	0.000356	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ENPP1—obesity	7.37e-05	0.000356	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—PIK3CD—obesity	7.31e-05	0.000353	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—FASN—obesity	7.23e-05	0.000349	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—BCHE—obesity	7.2e-05	0.000348	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—IL6—obesity	7.2e-05	0.000348	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—POMC—obesity	7.19e-05	0.000347	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PRL—obesity	7.17e-05	0.000346	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—HMGCS1—obesity	7.14e-05	0.000345	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—STK11—obesity	7.07e-05	0.000341	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—TNF—obesity	7.06e-05	0.000341	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CCL2—obesity	7.04e-05	0.00034	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PLG—obesity	6.99e-05	0.000337	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—RHOA—obesity	6.98e-05	0.000337	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ACADM—obesity	6.93e-05	0.000335	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—SAT1—obesity	6.93e-05	0.000335	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ANGPTL4—obesity	6.93e-05	0.000335	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PLIN1—obesity	6.93e-05	0.000335	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PFKFB3—obesity	6.93e-05	0.000335	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PNPLA2—obesity	6.93e-05	0.000335	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—AKT2—obesity	6.91e-05	0.000334	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—PIK3R1—obesity	6.91e-05	0.000333	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HDAC8—obesity	6.9e-05	0.000333	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—FOXO3—obesity	6.82e-05	0.000329	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—ADRB2—obesity	6.8e-05	0.000329	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CYTB—obesity	6.74e-05	0.000325	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—OXCT1—obesity	6.74e-05	0.000325	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ACACB—obesity	6.74e-05	0.000325	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—SOCS1—obesity	6.7e-05	0.000324	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PIK3CD—obesity	6.64e-05	0.000321	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—SOCS3—obesity	6.62e-05	0.00032	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PNLIP—obesity	6.57e-05	0.000317	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—SRD5A1—obesity	6.57e-05	0.000317	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—GNB3—obesity	6.48e-05	0.000313	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—SDC3—obesity	6.41e-05	0.00031	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—TYK2—obesity	6.39e-05	0.000309	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—GGT1—obesity	6.38e-05	0.000308	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—PIK3CB—obesity	6.37e-05	0.000308	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IGF2—obesity	6.36e-05	0.000307	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—RHOA—obesity	6.34e-05	0.000306	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—GNAS—obesity	6.31e-05	0.000305	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—NCOA1—obesity	6.28e-05	0.000303	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PIK3R1—obesity	6.27e-05	0.000303	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PCK1—obesity	6.27e-05	0.000303	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—STS—obesity	6.27e-05	0.000303	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CYP26B1—obesity	6.27e-05	0.000303	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—HK2—obesity	6.27e-05	0.000303	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—obesity	6.19e-05	0.000299	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—APOB—obesity	6.18e-05	0.000298	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PPARD—obesity	6.13e-05	0.000296	CbGpPWpGaD
Tafluprost—PTGS2—Disease—ACP5—obesity	6.1e-05	0.000295	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—obesity	6.07e-05	0.000293	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCL5—obesity	6.03e-05	0.000291	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—SLC27A1—obesity	6.01e-05	0.00029	CbGpPWpGaD
Tafluprost—PTGS2—Disease—G6PD—obesity	5.94e-05	0.000287	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—LPL—obesity	5.9e-05	0.000285	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—FABP4—obesity	5.89e-05	0.000284	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GLUL—obesity	5.89e-05	0.000284	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HK1—obesity	5.87e-05	0.000284	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—FOXO1—obesity	5.86e-05	0.000283	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—RPS6KB1—obesity	5.85e-05	0.000282	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PIK3CB—obesity	5.79e-05	0.00028	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—IL6—obesity	5.69e-05	0.000275	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PPARGC1A—obesity	5.68e-05	0.000274	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—HSD11B1—obesity	5.58e-05	0.00027	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—UCP3—obesity	5.58e-05	0.00027	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ECHS1—obesity	5.58e-05	0.00027	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—UCP2—obesity	5.58e-05	0.00027	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ADH1B—obesity	5.49e-05	0.000265	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PRKCD—obesity	5.43e-05	0.000262	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—APOB—obesity	5.41e-05	0.000261	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GPAM—obesity	5.41e-05	0.000261	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ACSL1—obesity	5.41e-05	0.000261	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PPARGC1B—obesity	5.41e-05	0.000261	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HTR2A—obesity	5.32e-05	0.000257	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—C3—obesity	5.31e-05	0.000256	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PCK1—obesity	5.25e-05	0.000254	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—HADH—obesity	5.25e-05	0.000254	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—FADS1—obesity	5.25e-05	0.000254	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—LPL—obesity	5.17e-05	0.00025	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—obesity	5.15e-05	0.000249	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—obesity	5.14e-05	0.000248	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ACP5—obesity	5.11e-05	0.000247	CbGpPWpGaD
Tafluprost—PTGS2—Disease—RBP4—obesity	5.05e-05	0.000244	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IRS2—obesity	5.05e-05	0.000244	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—AGT—obesity	5.05e-05	0.000244	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—GPX1—obesity	5.04e-05	0.000244	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—G6PD—obesity	4.98e-05	0.00024	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—APOE—obesity	4.94e-05	0.000239	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—LEP—obesity	4.94e-05	0.000239	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—SREBF2—obesity	4.92e-05	0.000237	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—HK1—obesity	4.92e-05	0.000237	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—CD36—obesity	4.91e-05	0.000237	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CAV1—obesity	4.9e-05	0.000237	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—APOA1—obesity	4.89e-05	0.000236	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—obesity	4.8e-05	0.000232	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CST3—obesity	4.79e-05	0.000231	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PRKAR2B—obesity	4.79e-05	0.000231	CbGpPWpGaD
Tafluprost—PTGS2—Disease—DCN—obesity	4.75e-05	0.000229	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—LPA—obesity	4.75e-05	0.000229	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—ESR1—obesity	4.72e-05	0.000228	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PRKCB—obesity	4.66e-05	0.000225	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—F2—obesity	4.66e-05	0.000225	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—LPIN1—obesity	4.65e-05	0.000224	CbGpPWpGaD
Tafluprost—PTGS2—Disease—NCF2—obesity	4.62e-05	0.000223	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—BAD—obesity	4.61e-05	0.000223	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PPARA—obesity	4.57e-05	0.000221	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—APOA5—obesity	4.55e-05	0.00022	CbGpPWpGaD
Tafluprost—PTGS2—Disease—NAMPT—obesity	4.53e-05	0.000219	CbGpPWpGaD
Tafluprost—PTGS2—Disease—GCK—obesity	4.5e-05	0.000218	CbGpPWpGaD
Tafluprost—PTGS2—Disease—IAPP—obesity	4.48e-05	0.000216	CbGpPWpGaD
Tafluprost—PTGS2—Disease—APOC3—obesity	4.48e-05	0.000216	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PIK3CG—obesity	4.46e-05	0.000216	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—AGT—obesity	4.42e-05	0.000214	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IRS1—obesity	4.41e-05	0.000213	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—obesity	4.37e-05	0.000211	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—SLC22A1—obesity	4.34e-05	0.00021	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CLOCK—obesity	4.34e-05	0.00021	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—APOE—obesity	4.33e-05	0.000209	CbGpPWpGaD
Tafluprost—PTGS2—Disease—SDC1—obesity	4.3e-05	0.000208	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—CAV1—obesity	4.29e-05	0.000207	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—APOA1—obesity	4.28e-05	0.000207	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—POMC—obesity	4.25e-05	0.000205	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—SULT2A1—obesity	4.23e-05	0.000204	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GLP1R—obesity	4.23e-05	0.000204	CbGpPWpGaD
Tafluprost—PTGS2—Disease—AKR1C3—obesity	4.23e-05	0.000204	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—INS—obesity	4.22e-05	0.000204	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—DPYD—obesity	4.16e-05	0.000201	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCL2—obesity	4.16e-05	0.000201	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IGF1—obesity	4.09e-05	0.000197	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—AKT2—obesity	4.08e-05	0.000197	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PRKAR2B—obesity	4.01e-05	0.000194	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—DCN—obesity	3.98e-05	0.000192	CbGpPWpGaD
Tafluprost—PTGS2—Disease—GOT2—obesity	3.93e-05	0.00019	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PIK3CD—obesity	3.92e-05	0.000189	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—obesity	3.91e-05	0.000189	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—PIK3CA—obesity	3.89e-05	0.000188	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—SERPINE1—obesity	3.88e-05	0.000187	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CPT1A—obesity	3.87e-05	0.000187	CbGpPWpGaD
Tafluprost—PTGS2—Disease—FASN—obesity	3.85e-05	0.000186	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PARP1—obesity	3.83e-05	0.000185	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—NAMPT—obesity	3.8e-05	0.000183	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PPARG—obesity	3.77e-05	0.000182	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TYK2—obesity	3.77e-05	0.000182	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—LIPC—obesity	3.77e-05	0.000182	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GCK—obesity	3.77e-05	0.000182	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—APOC3—obesity	3.75e-05	0.000181	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—RHOA—obesity	3.74e-05	0.000181	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—POMC—obesity	3.72e-05	0.00018	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PIK3R1—obesity	3.7e-05	0.000179	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NOS3—obesity	3.7e-05	0.000179	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CETP—obesity	3.64e-05	0.000176	CbGpPWpGaD
Tafluprost—PTGS2—Disease—NOS1—obesity	3.6e-05	0.000174	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—SDC1—obesity	3.6e-05	0.000174	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—obesity	3.57e-05	0.000173	CbGpPWpGaD
Tafluprost—PTGS2—Disease—TCF7L2—obesity	3.56e-05	0.000172	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—AKR1C3—obesity	3.54e-05	0.000171	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PIK3CA—obesity	3.53e-05	0.00017	CbGpPWpGaD
Tafluprost—PTGS2—Disease—SLC2A4—obesity	3.5e-05	0.000169	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—SCARB1—obesity	3.49e-05	0.000168	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—obesity	3.44e-05	0.000166	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MTOR—obesity	3.42e-05	0.000165	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PIK3CB—obesity	3.42e-05	0.000165	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—ALB—obesity	3.39e-05	0.000164	CbGpPWpGaD
Tafluprost—PTGS2—Disease—GOT1—obesity	3.39e-05	0.000164	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—SREBF1—obesity	3.38e-05	0.000163	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PRL—obesity	3.34e-05	0.000161	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GOT2—obesity	3.29e-05	0.000159	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—obesity	3.25e-05	0.000157	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—FASN—obesity	3.22e-05	0.000156	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—BCHE—obesity	3.21e-05	0.000155	CbGpPWpGaD
Tafluprost—PTGS2—Disease—FOXO3—obesity	3.18e-05	0.000154	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—AKT1—obesity	3.17e-05	0.000153	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—IL6—obesity	3.12e-05	0.000151	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CYP2E1—obesity	3.09e-05	0.000149	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—NQO1—obesity	3.06e-05	0.000148	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—obesity	3e-05	0.000145	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MMP9—obesity	2.97e-05	0.000144	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GCG—obesity	2.93e-05	0.000142	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—SLC2A4—obesity	2.93e-05	0.000142	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CYCS—obesity	2.9e-05	0.00014	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MAPK8—obesity	2.89e-05	0.00014	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—AKT1—obesity	2.88e-05	0.000139	CbGpPWpGaD
Tafluprost—PTGS2—Disease—APOB—obesity	2.88e-05	0.000139	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GOT1—obesity	2.84e-05	0.000137	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GGT1—obesity	2.84e-05	0.000137	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—NCOA1—obesity	2.8e-05	0.000135	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—STK11—obesity	2.76e-05	0.000133	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CYP19A1—obesity	2.76e-05	0.000133	CbGpPWpGaD
Tafluprost—PTGS2—Disease—LPL—obesity	2.75e-05	0.000133	CbGpPWpGaD
Tafluprost—PTGS2—Disease—FOXO1—obesity	2.73e-05	0.000132	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—STAT3—obesity	2.64e-05	0.000128	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—COMT—obesity	2.56e-05	0.000124	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PRKCD—obesity	2.53e-05	0.000122	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PPARGC1A—obesity	2.53e-05	0.000122	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GNB3—obesity	2.53e-05	0.000122	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—HMOX1—obesity	2.52e-05	0.000122	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MTHFR—obesity	2.47e-05	0.00012	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GNAS—obesity	2.46e-05	0.000119	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MYC—obesity	2.46e-05	0.000119	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TGFB1—obesity	2.45e-05	0.000118	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—APOB—obesity	2.41e-05	0.000116	CbGpPWpGaD
Tafluprost—PTGS2—Disease—IRS2—obesity	2.35e-05	0.000114	CbGpPWpGaD
Tafluprost—PTGS2—Disease—APOE—obesity	2.3e-05	0.000111	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—LPL—obesity	2.3e-05	0.000111	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CAV1—obesity	2.28e-05	0.00011	CbGpPWpGaD
Tafluprost—PTGS2—Disease—APOA1—obesity	2.28e-05	0.00011	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GPX1—obesity	2.25e-05	0.000108	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CD36—obesity	2.19e-05	0.000106	CbGpPWpGaD
Tafluprost—PTGS2—Disease—BAD—obesity	2.15e-05	0.000104	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PIK3CA—obesity	2.08e-05	0.000101	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—MTHFR—obesity	2.07e-05	0.0001	CbGpPWpGaD
Tafluprost—PTGS2—Disease—IRS1—obesity	2.06e-05	9.93e-05	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PPARA—obesity	2.03e-05	9.82e-05	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—AGT—obesity	1.97e-05	9.51e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—INS—obesity	1.97e-05	9.51e-05	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—APOE—obesity	1.93e-05	9.32e-05	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CAV1—obesity	1.91e-05	9.23e-05	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—APOA1—obesity	1.91e-05	9.21e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—AKT2—obesity	1.9e-05	9.19e-05	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IL6—obesity	1.85e-05	8.91e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PIK3CD—obesity	1.83e-05	8.83e-05	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.83e-05	8.82e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—SERPINE1—obesity	1.81e-05	8.73e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—TYK2—obesity	1.76e-05	8.49e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—RHOA—obesity	1.74e-05	8.42e-05	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PIK3CG—obesity	1.74e-05	8.41e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PIK3R1—obesity	1.73e-05	8.34e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—NOS3—obesity	1.73e-05	8.34e-05	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—AKT1—obesity	1.7e-05	8.22e-05	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PPARG—obesity	1.68e-05	8.12e-05	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—POMC—obesity	1.66e-05	8.01e-05	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—INS—obesity	1.65e-05	7.96e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MTOR—obesity	1.59e-05	7.69e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PIK3CB—obesity	1.59e-05	7.69e-05	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PIK3CD—obesity	1.53e-05	7.39e-05	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ALB—obesity	1.51e-05	7.3e-05	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PIK3R1—obesity	1.45e-05	6.98e-05	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—NOS3—obesity	1.45e-05	6.98e-05	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PIK3CB—obesity	1.33e-05	6.44e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—STAT3—obesity	1.23e-05	5.95e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MYC—obesity	1.14e-05	5.53e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—TGFB1—obesity	1.14e-05	5.51e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PIK3CA—obesity	9.71e-06	4.69e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—IL6—obesity	8.6e-06	4.15e-05	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PIK3CA—obesity	8.13e-06	3.93e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—AKT1—obesity	7.93e-06	3.83e-05	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—AKT1—obesity	6.65e-06	3.21e-05	CbGpPWpGaD
